Transparency Market Research Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Published Date 17-Oct-2014
188 Page Report
Buy Now
Request Sample
Press Release
Global Hospital Pharmaceuticals Market Expected to Reach USD 11.6 Billion in 2020: Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Hospital Pharmaceuticals Market
REPORT DESCRIPTION
Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 According to a new market report published by Transparency Market Research "Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" the global hospital pharmaceuticals market was valued at USD 26.5 billion in 2013 and is estimated to reach USD 11.6 billion by 2020 declining with a CAGR of (10.5)% from 2014 to 2020. The report defines hospital pharmaceuticals as drugs that are exclusively administered in hospital and professional healthcare facilities that encompass both in-patient as well as out-patient departments. Hospital pharmaceuticals market which had been experiencing slumps in past three to four years due to economic slowdown, patent and exclusivity loss of various orphan and blockbuster drugs is expected to recover at a rapid pace. Over a decade there has been a considerable rise in several chronic disorders that can only be treated in hospital setting such as renal failure, canter, stroke, Alzheimer's disease and angina which is expected to boost hospital pharmaceuticals market in forthcoming years. Browse the full Hospital Pharmaceuticals Market: http://www.transparencymarketresearch.com/hospital-pharmaceuticals-market.html According to World Health Organization (WHO), coronary heart diseases across the globe accounts for over 7.5 million mortalities annually. Moreover as per an analysis by Centers for Disease Control and Prevention (CDC), each year stroke kills approximately 130,000 Americans of which about 87% of them are ischemic strokes. Approximately 5.1 million people in the United States suffered from heart failure in 2013. The aforementioned statistics clearly depict the latent potential for growth owing to substantial rise in various disease indications which in last two years accounted for major source of revenue for hospital pharmacies. The report studies the hospital pharmaceuticals market from two perspectives: major therapeutic class and indications. Market by therapeutic class includes all major drug classes that are majorly prescribed and sold in hospital pharmacies. Market by indication is segmented into six major disorders: cardiology, oncology, nephrology and urology, neurology, pain and anti-infectives. Among the mentioned indications, oncology and cardiology are key markets share declining at a CAGR of (13.01)% and (9.38)% respectively. Decline in growth rate for both the markets is majorly attributed to increasing number of drugs losing their exclusivity during the forecast period (2014-2020). Billion dollar cardiovascular medicines that are getting off patent include Exforge HCT (amlodipine/hydrochlorothiazide/valsartan), Benicar HCT (hydrochlorothiazide and olmesartan) and VESIcare (Solifenacin Succinate) in 2014, 2016 and 2018 respectively. Furthermore various billion dollar oncology drugs which will get off patent in next 5 years comprise Gleevec (Imatinib Mesylate), Tarceva (erlotinib), Zytiga (Abiraterone Acetate) and Velcade (bortezomib).
Transparency Market Research
2
Hospital Pharmaceuticals Market
Get report sample PDF copy from here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3535 Rise in emergency department visits and increased per capita spending of patients across the globe are some of the major drivers escalating the growth of the overall market. Emergency department visits accounted for 7.4% of the total hospital visits in the U.S. in 2011 compared to 2.3% in 2010. Healthcare Cost and Utilization Project (HCUP) statistical brief data estimated that emergency department discharges increased five times (359 patients per 1,000 people) in the U.S. in 2011 compared to 2010. A large number of new molecular entities are also anticipated to be launched during the forecast period. These primarily include therapeutic areas such as cancer, neurological disorders, infections and cardiovascular diseases. All these factors would increase the global spending on medicines. Moreover, global spending on medicines is expected to increase from USD 1 trillion in 2014 to USD 1.2 trillion by 2017. Such factors are expected to boost the market for hospital pharmaceuticals market especially in case of generic drugs. Geographically, North America market accounted for the largest share in 2013 due to 2013 due to favorable reimbursement policies, high awareness, rising per capita income, increased spending on the healthcare and greater depth of marketing efforts by key players. Total spending on healthcare in the U.S. increased from USD 320 million in 2012 to USD 330 million in 2013 depicting an increase of per capita spending by 1%. Presence of sound intellectual property in the European Union countries and presence of high quality pharmaceutical research organizations are among the few prominent drivers. Whereas, fragmented pricing system and improper reimbursement scenario and regulatory framework for clinical trials are key restraints to the European hospital pharmaceuticals market. Asia Pacific and Rest of the World are among the fastest growing markets for hospital pharmaceuticals due to the presence of large population base, aging population suffering from chronic diseases and increasing disposable income. Leading market players in this market include AstraZeneca plc, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc., Sanofi -Aventis. The hospital pharmaceuticals market is segmented as follows: Global Hospital Pharmaceuticals Market, by Major Therapeutic Class Cardiology Anti-Adrenergic Drugs Calcium Channel Blockers Diuretic Drugs Anti-Arrhythmic Drugs Others
Oncology
Transparency Market Research
3
Hospital Pharmaceuticals Market
Alkylating Agents Anti-Metabolites Hormonal Agents Immunomodulating Agents Miscellaneous Drugs
Nephrology and Urology Diuretic Agents Anti-Hypertensive Agents Phosphate Binders Anticholinergic Drugs 5-Alpha Reductase Inhibitors
Neurology Anti-Anxiety Agents Detail2Anti-Migraine Drugs Antidepressant Drugs Anti-Psychotic Drugs
Pain Anticonvulsant Drugs Anesthetic Drugs Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Opioids Non-Narcotics Analgesic Drugs
Transparency Market Research
4
Hospital Pharmaceuticals Market
Infection Antibacterial Drugs Antiviral Drugs Antifungal Drugs Antiparasite Drugs
Global Hospital Pharmaceuticals Market, by Major Indications
Cardiology Coronary Heart Diseases Stroke High Blood Pressure Heart Failure Others
Oncology Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Others
Nephrology and Urology Acute Kidney Failure
Transparency Market Research
5
Hospital Pharmaceuticals Market
Chronic Kidney Diseases Glomerular Diseases Diabetes Others
Neurology Epilepsy Alzheimer;s Disease Parkinson;s Disease Multiple Sclerosis Others
Pain Neuropathic Pain Fibromyalgia Osteoarthritis Rheumatoid Arthritis Cancer Pain
Infection Detail1Tuberculosis Pneumonia Hepatitis A Hepatitis B Candida Infection
Transparency Market Research
6
Hospital Pharmaceuticals Market
Fungal Meningitis Shigellosis Amoebiasis Other
Global Hospital Pharmaceuticals Market, by Geography
North America Europe Asia Pacific Rest of the World (RoW)
Browse the full Hospital Pharmaceuticals Market: http://www.transparencymarketresearch.com/hospital-pharmaceuticals-market.html
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Secondary Research 1.3.2 Primary Research 1.4 Assumptions
Transparency Market Research
7
Hospital Pharmaceuticals Market
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Hospital Pharmaceuticals Market 2.2 Comparative Analysis: Global Hospital Pharmaceuticals Market, by Geography, 2013 & 2020 (Value %)
Chapter 3 Global Hospital Pharmaceutical Market Overview 3.1 Market Definition and Overview 3.2 Event Impact Analysis 3.3 Market Dynamics 3.3.1 Market Drivers 3.3.1.1 Increased emergency department visits driving the demand for specialty drugs in hospital settings 3.3.1.2 Increased spending on medicines driving the hospital pharmaceuticals market 3.3.2 Market Restraints 3.3.2.1 Patent expirations of blockbuster drugs would result in decline in hospital pharmaceuticals market 3.3.2.2 Decreased hospital visits among geriatric population negatively affecting the hospital pharmaceuticals market 3.3.3 Market Opportunities 3.3.3.1 Extensive research and development activities would lead to introduction of new drugs in the market 3.3.3.2 Increasing number of hospitals in developing economies and improving healthcare sector would drive the hospital pharmaceuticals market in these regions
Transparency Market Research
8
Hospital Pharmaceuticals Market
3.3.3.3 Increasing prevalence of diseases across the world would fuel the growth of the hospital pharmaceuticals market 3.4 Regulatory Framework 3.5 Value Chain Analysis 3.6 Porter’s Five Forces Analysis: Global Hospital Pharmaceuticals Market 3.6.1 Bargaining Power of Suppliers 3.6.2 Bargaining Power of Buyers 3.6.3 Threat of Substitutes 3.6.4 Threat of New Entrants 3.6.5 Competitive Rivalry 3.7 Market Attractiveness Analysis: Global Hospital Pharmaceuticals Market 3.8 Market Share Analysis: Global Hospital Pharmaceuticals Market 3.8.1 Market Share Analysis: Global Hospital Pharmaceutical Market, by Key Players, 2013 (Value %)
Chapter 4 Global Hospital Pharmaceutical Market, by Major Therapeutic Class 4.1 Introduction 4.1.1 Global Hospital Pharmaceuticals Market Revenue, by Major Therapeutic Areas, 2012-2020 (USD Million) 4.2 Cardiology 4.2.1 Global Hospital Pharmaceuticals Market Revenue, by Cardiology, 2012-2020 (USD Million) 4.2.2 Anti-Adrenergic Drugs 4.2.2.1 Global Hospital Pharmaceuticals Market Revenue, by Anti-Adrenergic Drugs 2012 – 2020 (USD Million)
Transparency Market Research
9
Hospital Pharmaceuticals Market
4.2.3 Calcium Channel Blockers 4.2.3.1 Global Hospital Pharmaceuticals Market Revenue, by Calcium Channel Blockers, 2012 – 2020 (USD Million) 4.2.4 Diuretic Drugs 4.2.4.1 Global Hospital Pharmaceuticals Market Revenue, by Diuretic Drugs, 2012 – 2020 (USD Million) 4.2.5 Anti-Arrhythmic Drugs 4.2.5.1 Global Hospital Pharmaceuticals Market Revenue, by Anti-Arrhythmic Drugs, 2012 – 2020 (USD Million) 4.2.6 Others 4.2.6.1 Global Hospital Pharmaceuticals Market Revenue, by Other Cardiology Drugs, 2012 – 2020 (USD Million) 4.3 Oncology 4.3.1 Global Hospital Pharmaceuticals Market Revenue, by Oncology, 2012-2020 (USD Million) 4.3.2 Alkylating Agents 4.3.2.1 Global Hospital Pharmaceuticals Market Revenue, by Alkylating Agents 2012 – 2020 (USD Million) 4.3.3 Anti-Metabolites 4.3.3.1 Global Hospital Pharmaceuticals Market Revenue, by Anti-Metabolites 2012 – 2020 (USD Million) 4.3.4 Hormonal Agents 4.3.4.1 Global Hospital Pharmaceuticals Market Revenue, by Hormonal Agents 2012 – 2020 (USD Million) 4.3.5 Immunomodulating Agents
Transparency Market Research
10
Hospital Pharmaceuticals Market
4.3.5.1 Global Hospital Pharmaceuticals Market Revenue, by Immunomodulating Agents 2012 – 2020 (USD Million) 4.3.6 Miscellaneous Drugs 4.3.6.1 Global Hospital Pharmaceuticals Market Revenue, by Miscellaneous Drugs 2012 – 2020 (USD Million) 4.4 Nephrology and Urology 4.4.1 Global Hospital Pharmaceuticals Market Revenue, by Nephrology and Urology, 2012-2020 (USD Million) 4.4.2 Diuretic Agents 4.4.2.1 Global Hospital Pharmaceuticals Market Revenue, by Diuretic Agents 2012 – 2020 (USD Million) 4.4.3 Anti-Hypertensive Agents 4.4.3.1 Global Hospital Pharmaceuticals Market Revenue, by Anti-Hypertensive Agents 2012 – 2020 (USD Million) 4.4.4 Phosphate Binders 4.4.4.1 Global Hospital Pharmaceuticals Market Revenue, by Phosphate Binders, 2012 – 2020 (USD Million) 4.4.5 Anticholinergic Drugs 4.4.5.1 Global Hospital Pharmaceuticals Market Revenue, by Anticholinergic Drugs, 2012 – 2020 (USD Million) 4.4.6 5-Alpha Reductase Inhibitors 4.4.6.1 Global Hospital Pharmaceuticals Market Revenue, by 5-Alpha Reductase Inhibitors, 2012 – 2020 (USD Million) 4.5 Neurology 4.5.1 Global Hospital Pharmaceuticals Market Revenue, by Neurology, 2012-2020 (USD Million)
Transparency Market Research
11
Hospital Pharmaceuticals Market
4.5.2 Anti-Anxiety Agents 4.5.2.1 Global Hospital Pharmaceuticals Market Revenue, by Anti-anxiety Agents, 2012 – 2020 (USD Million) 4.5.3 Anti-Migraine Drugs 4.5.3.1 Global Hospital Pharmaceuticals Market Revenue, by Anti-Migraine Drugs, 2012 – 2020 (USD Million) 4.5.4 Antidepressant Drugs 4.5.4.1 Global Hospital Pharmaceuticals Market Revenue, by Antidepressant Drugs, 2012 – 2020 (USD Million) 4.5.5 Anti-Psychotic Drugs 4.5.5.1 Global Hospital Pharmaceuticals Market Revenue, by Anti-Psychotic Drugs, 2012 – 2020 (USD Million) 4.6 Pain 4.6.1 Global Hospital Pharmaceuticals Market Revenue, by Pain, 2012-2020 (USD Million) 4.6.2 Anticonvulsant Drugs 4.6.2.1 Global Hospital Pharmaceuticals Market Revenue, by Anticonvulsant Drugs, 2012 – 2020 (USD Million) 4.6.3 Anesthetic Drugs 4.6.3.1 Global Hospital Pharmaceuticals Market Revenue, by Anaesthetic Drugs, 2012 – 2020 (USD Million) 4.6.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 4.6.4.1 Global Hospital Pharmaceuticals Market Revenue, by Non-Steroidal Anti-Inflammatory Drugs, 2012 – 2020 (USD Million) 4.6.5 Opioids
Transparency Market Research
12
Hospital Pharmaceuticals Market
4.6.5.1 Global Hospital Pharmaceuticals Market Revenue, by Opioids, 2012 – 2020 (USD Million) 4.6.6 Non-Narcotics Analgesic Drugs 4.6.6.1 Global Hospital Pharmaceuticals Market Revenue, by Non-Narcotics Analgesic Drugs, 2012 – 2020 (USD Million) 4.7 Infection 4.7.1 Global Hospital Pharmaceuticals Market Revenue, by Infection, 2012-2020 (USD Million) 4.7.2 Antibacterial Drugs 4.7.2.1 Global Hospital Pharmaceuticals Market Revenue, by Antibacterial Drugs, 2012 – 2020 (USD Million) 4.7.3 Antiviral Drugs 4.7.3.1 Global Hospital Pharmaceuticals Market Revenue, by Antiviral Drugs, 2012 – 2020 (USD Million) 4.7.4 Antifungal Drugs 4.7.4.1 Global Hospital Pharmaceuticals Market Revenue, by Antifungal Drugs, 2012 – 2020 (USD Million) 4.7.5 Antiparasite Drugs 4.7.5.1 Global Hospital Pharmaceuticals Market Revenue, by Antiparasite Drugs, 2012 – 2020 (USD Million)
Chapter 5 Global Hospital Pharmaceutical Market, by Indication 5.1 Introduction 5.2 Cardiology 5.2.1 Global Hospital Pharmaceuticals Market Revenue, by Cardiology Indications, 2012-2020 (USD Million)
Transparency Market Research
13
Hospital Pharmaceuticals Market
5.2.1.1 Coronary Heart Diseases 5.2.1.2 Global Coronary Heart Diseases Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.2.2 Stroke 5.2.2.1 Global Stroke Hospital Pharmaceuticals Market Revenue,2012 – 2020 (USD Million) 5.2.3 High Blood Pressure 5.2.3.1 Global High Blood Pressure Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.2.4 Heart Failure 5.2.4.1 Global Heart Failure Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.2.5 Others 5.2.5.1 Global Other Cardiology Indications Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.3 Oncology 5.3.1 Global Hospital Pharmaceuticals Market Revenue, by Oncology Indications, 2012-2020 (USD Million) 5.3.2 Lung Cancer 5.3.2.1 Global Lung Cancer Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.3.3 Breast Cancer 5.3.3.1 Global Breast Cancer Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.3.4 Colorectal Cancer 5.3.4.1 Global Colorectal Cancer Hospital Pharmaceuticals Market Revenue, 2012 – 2020, (USD Million)
Transparency Market Research
14
Hospital Pharmaceuticals Market
5.3.5 Prostate Cancer 5.3.5.1 Global Prostate Cancer Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.3.6 Others 5.3.6.1 Global Other Cancers Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.4 Nephrology and Urology 5.4.1 Global Hospital Pharmaceuticals Market Revenue, by Nephrology and Urology Indications, 20122020 (USD Million) 5.4.2 Acute Kidney Failure 5.4.2.1 Global Acute Kidney Failure Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.4.3 Chronic Kidney Diseases 5.4.3.1 Global Chronic Kidney Diseases Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.4.4 Glomerular Diseases 5.4.4.1 Global Glomerular Diseases Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.4.5 Diabetes 5.4.5.1 Global Diabetes Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.4.6 Others 5.4.6.1 Global Other Nephrology And Urology Indications Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.5 Neurology
Transparency Market Research
15
Hospital Pharmaceuticals Market
5.5.1 Global Hospital Pharmaceuticals Market Revenue, by Neurology Indications, 2012-2020 (USD Million) 5.5.2 Epilepsy 5.5.2.1 Global Epilepsy Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.5.3 Alzheimer’s Disease 5.5.3.1 Global Alzheimer’s Disease Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.5.4 Parkinson’s Disease 5.5.4.1 Global Parkinson’s Disease Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.5.5 Multiple Sclerosis 5.5.5.1 Global Multiple Sclerosis Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.5.6 Others 5.5.6.1 Global Other Neurology Indications Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.6 Pain 5.6.1 Global Hospital Pharmaceuticals Market Revenue, by Pain Indications, 2012-2020 (USD Million) 5.6.2 Neuropathic Pain 5.6.2.1 Global Neuropathic Pain Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.6.3 Fibromyalgia 5.6.3.1 Global Fibromyalgia Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.6.4 Osteoarthritis
Transparency Market Research
16
Hospital Pharmaceuticals Market
5.6.4.1 Global Osteoarthritis Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.6.5 Rheumatoid Arthritis 5.6.5.1 Global Rheumatoid Arthritis Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.6.6 Cancer Pain 5.6.6.1 Global Cancer Pain Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.7 Infection 5.7.1 Global Hospital Pharmaceuticals Market Revenue, by Infection, 2012-2020 (USD Million) 5.7.2 Tuberculosis 5.7.2.1 Global Tuberculosis Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.7.3 Pneumonia 5.7.3.1 Global Pneumonia Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.7.4 Hepatitis A 5.7.4.1 Global Hepatitis A Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.7.5 Hepatitis B 5.7.5.1 Global Hepatitis B Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.7.6 Candida Infection 5.7.6.1 Global Candida Infection Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.7.7 Fungal Meningitis 5.7.7.1 Global Hospital Pharmaceuticals Market Revenue, by Fungal Meningitis, 2012 – 2020 (USD Million) 5.7.8 Shigellosis
Transparency Market Research
17
Hospital Pharmaceuticals Market
5.7.8.1 Global Shigellosis Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.7.9 Amoebiasis 5.7.9.1 Global Amoebiasis Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million) 5.7.10 Other Infections 5.7.10.1 Global Other Infections Hospital Pharmaceuticals Market Revenue, 2012 – 2020 (USD Million)
Chapter 6 Hospital Pharmaceuticals Market, by Geography 6.1 Introduction 6.1.1 Global Hospital Pharmaceuticals Market Revenue, by Geography, 2012-2020 (USD Million) 6.2 North America 6.2.1 North America Hospital Pharmaceuticals Market Revenue, 2012 -2020 (USD Million) 6.3 Europe 6.3.1 Europe Hospital Pharmaceuticals Market Revenue, 2012 -2020 (USD Million) 6.4 Asia Pacific 6.4.1 Asia Pacific Hospital Pharmaceuticals Market Revenue, 2012 -2020 (USD Million) 6.5 Rest of the World 6.5.1 Rest of the World Hospital Pharmaceuticals Market Revenue, 2012 -2020 (USD Million)
Chapter 7 Recommendations 7.1 Collaboration and distribution agreement with local manufactures in emerging market to enhance revenue and market share of new and established players
Transparency Market Research
18
Hospital Pharmaceuticals Market
7.2 Biological drugs to become next future of the pharmaceuticals market 7.3 Focus on oncology based therapeutics
Chapter 8 Company Profiles 8.1 AstraZeneca plc 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Bayer AG 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 Bristol-Myers Squibb Company 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments
Transparency Market Research
19
Hospital Pharmaceuticals Market
8.4 Eli Lilly and Company 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 GlaxoSmithKline plc 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Johnson & Johnson 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Merck & Co., Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio
Transparency Market Research
20
Hospital Pharmaceuticals Market
8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Novartis AG 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Pfizer, Inc. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments 8.10 Sanofi-Aventis 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Recent Developments Browse the full Hospital Pharmaceuticals Market Report at http://www.transparencymarketresearch.com/hospital-pharmaceuticals-market.html
Transparency Market Research
21
Hospital Pharmaceuticals Market
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
22